Dong-A ST Co., Ltd.
170900.KS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$328.2B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $328.20 Billion |
|---|---|
| Enterprise Value | $679.79 Billion |
| Annual dividend | $700.00 |
| Dividend yield | 2.06% |
| Earnings per Share | $-2970.54 |
| Beta | 0.4 |
| Outstanding Shares | 9,643,000 |
Return
| Return on Equity | 0.45% |
|---|---|
| Return on Assets | 0.22% |
| Return on Invested Capital | -7.24% |
Valuation & Multiples
| P/E Ratio | -55.69 |
|---|---|
| PEG | 48.26 |
| Price to Sales | 0.38 |
| Price to Book Ratio | 0.49 |
| Enterprise Value to Revenue | 0.79 |
| Enterprise Value to EBIT | -10.05 |
| Enterprise Value to Net Income | 232 |
| Total Debt to Enterprise | 0.72 |
| Debt to Equity | 0.75 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 28, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$216.18 B
Consensus analyst estimateNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$229.73 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Dong-A ST Co., Ltd.
1,685 employees
CEO: Jae-Hun Jung
Dong-A ST Co., Ltd. is a global enterprise focused on the research, development, production, and commercialization of a broad spectrum of pharmaceutical products and medical devices. The company's diverse portfolio of ethical drugs targe...